Products for Research Use Only

Gadodiamide (hydrate)

CAT: 0804-HY-B0266-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0266-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
122795-43-1
UNSPSC Description
Gadodiamide hydrate is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Target: Others Gadodiamide hydrate is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. Gadodiamide hydrate is a contrast medium for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. The product provides contrast enhancement and facilitates visualisation of abnormal structures or lesions in various parts of the body including the central nervous system (CNS). A recent review takes the question of toxicity caused by loss of gadolinium from the complex. "The challenge for nephrologists includes (a) evidence of transmetallation, such as gadolinium deposits in bone, increased urinary zinc excretion, iron-transferrin dissociation or 'spurious hypocalcemia' in exposed people" [1].
Target Antigen
Biochemical Assay Reagents
Type
Reference compound
Related Pathways
Others
Field of Research
Others
Purity
99.02
Solubility
DMSO : 50 mg/mL (ultrasonic)|H2O : 100 mg/mL (ultrasonic)
Smiles
CNC1=O[Gd+3]([N]2(C3)CC4)([N]5(C6)CC2)(O=C(NC)C5)([O-]C7=O)([O-]C6=O)([O-]C3=O)[N]4(C7)C1.O
Molecular Weight
591.67
References & Citations
[1]Canavese, C., et al., Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness. J Nephrol, 2008. 21(3): p. 324-36.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Clinical Information
Launched